The effect of sectoral, scatter laser photocoagulation on proliferative sickle retinopathy (PSR) was investigated by reviewing fluorescein angiograms of 88 sickle cell haemoglobin C patients enrolled in a controlled, random ised trial. Follow-up was for a median period of2.9 years.
Proliferative sickle retinopathy (P SR) may be com plicated by vitreous haemorrhage and retinal detach ment. 1 Treatment modalities advocated to prevent the blinding complications of PSR have included diathermy, 2 cryotherapy 3 and feeder vessel coagulation. 4 PSR regres sion has been reported following uncontrolled studies of sectora1 5 and circumferentia1 6 scatter laser photocoag ulation. A controlled, randomised trial of sectoral, scatter laser photocoagulation for PSR has demonstrated a sig nificant reduction in visual loss in treated eyes. 7 This study reports the effect of la s er photocoagulation on PSR behaviour in sickle cell-haemoglobin C (SC) patients participating in that trial.
PATIENTS AND METHODS
Patients attending the Sickle Cell Clinic at the University of the West Indies were invited to participate in a control led, randomised study of sectoral, scatter laser photocoag ulation for perfused PSR. 7 Informed consent was obtained Eye (1993) 7, 703-706 from all patients prior to enrolment. The majority of the patients in the trial had SC disease and to avoid differences in behaviour between genotypes only SC eyes were com pared in this study. Eyes with cataract or vitreous haemor rhage that would have prevented laser photocoagulation were excluded from the study, as were eyes with retinal detachment, previous photocoagulation, ocular surgery and eyes that had participated in previous studies of feeder vessel photocoagulation. 8 , 9 Patients with �iabetes mellitus or systemic hypertension were also excluded. Patients with unilateral PSR or with only one eligible eye were randomly assigned to treatment or control groups (ratio 2:1 by computer-generated randomisation). lethe second eye subsequently developed PSR or if vitreous haemor rhage cleared then it received the opposite modality. Patients with bilateral PSR had the right eye randomised; the left eye received the opposite modality. The size and elevation of the PSR lesion was docu mented at each visit, a small lesion being defined as < 15° circumferential involvement. Treated eyes had blue/green argon laser (Britt 3250) bums 500 !lm in diameter, 0.1 s duration, placed around the PSR lesion. Treatment extended 1 mm anterior and posterior and 1 clock hour each side of the lesion (Figs. 1, 2) and sufficient power was used to produce mild whitening of the retina. The number of bums used depended on the size of the PSR lesion. Subsequent behaviour was assessed by serial fluorescein angiograms performed at 6 monthly intervals. Regression of proliferative disease was defined as a decrease in size or number of PSR lesions on angiography. Survival curve analysis was used to compare behaviour (regression) between treated and control eyes and differ ences were assessed by the logrank test. Logistic regres sion analysis, which allowed for different lengths of follow-up between eyes, was used to compare the fre quency of development of new PSR lesions and differ ences were assessed by the X 2 test. For the purpose of this analysis, all patients with both eyes entered in to the trial at any time were considered to be bilateral cases. 
RESULTS
A total of 88 SC patients (134 eyes) were reviewed. There were 46 bilateral and 42 unilateral cases. Of the 46 bilat eral cases, 16 had unilateral PSR when initially enrolled but during the study period PSR developed in the fellow eye, which then entered the trial. The remaining 30 bilat eral cases had bilateral PSR when first enrolled. Of the 42 unilateral cases, 20 (15 treated, 5 control) had unilateral PSR and 22 (13 treated, 9 control) had bilateral PSR but only one eye was eligible for entry in to the trial. Of these 22 unilateral cases, 15 (7 treated, 8 control) had PSR in the fellow eye which had previously been treated, 2 (I treated, I control) had spontaneously non-perfused PSR in the fel- 
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low eye, 4 (treated) had a retinal detachment in the fellow eye and I (treated) had vitreous haemorrhage in the fellow eye.
A total of 74 treated SC eyes and 60 control SC eyes were observed for a median period of 2.9 years (range 0.1-7.2 years). At enrolment 30 of 74 treated eyes and 25 of 60 control eyes were in patients aged < 25 years. At the initial examination 237 of 328 (72%) PSR lesions were small « 150 circumferential involvement) and 127 of 328 (39%) were flat. During the study a further 92 PSR lesions developed. Table I shows the number ofPSR lesions pres ent in treated and control eyes at the end of the study. Treated eyes contained 174 small and 59 large PSR lesions at the end of the study, of which 104 were flat and 129 were elevated. Control eyes contained 153 small and 34 large PSR lesions at the end of the study, of which 95 were flat and 92 were elevated. There were no significant differ ences between treated and control eyes in the number, size and type of PSR lesions. Follow-up of control eyes revealed no significant age or sex difference in regression of PSR. Treated and control eyes were then compared. Only 7 of 74 treated eyes and 2 of 60 control eyes had no perfused PSR lesions at the last visit <X 2 = 0.95, p = 0.3). Treated eyes had more PSR regression (decrease in size or number of PSR lesions on angiography) than control eyes, but this effect was only significant in patients aged <25 years at enrolment <X l = 11.5, p<O.OOI), not in older patients <X 2 = 0.25, p = 0.6).
Analysis of the behaviour of individual PSR lesions revealed significantly more infarction in treated eyes <X l = 12.7,p<0.001) (Fig. 3) . Of the treated PSR lesions, infarction occurred more frequently if the lesions were small <X 2 = 16.4, p<O.OOI) and if they were flat rather than elevated (X " = 20.5, p<O.OOI). During follow-up, new PSR lesions developed in 25 of 74 (34%) treated eyes and 35 of 60 (58%) control eyes. Using logistic regression analysis, significantly fewer new lesions developed in treated eyes (X l = 9.9, p = 0.002). In treated eyes most new PSR lesions developed circumfer ential to the treated areas. PSR developed within the treat ment area in only 2 eyes and posterior to the treatment area in 3 eyes. There were no complications attributable to scatter laser photocoagulation. 
